Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Garden Biopharmaceutical Co Additional Paid-In Capital?

Zhejiang Garden Biopharmaceutical Co's quarterly additional paid-in capital declined from Sep. 2024 (¥0 Mil) to Dec. 2024 (¥-77 Mil) but then increased from Dec. 2024 (¥-77 Mil) to Mar. 2025 (¥0 Mil).

Zhejiang Garden Biopharmaceutical Co's annual additional paid-in capital declined from Dec. 2022 (¥-46 Mil) to Dec. 2023 (¥-46 Mil) and declined from Dec. 2023 (¥-46 Mil) to Dec. 2024 (¥-77 Mil).

Zhejiang Garden Biopharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for Zhejiang Garden Biopharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Garden Biopharmaceutical Co Additional Paid-In Capital Chart

Zhejiang Garden Biopharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

Get a 7-Day Free Trial

980.90

-46.28

-46.30

-76.76

Zhejiang Garden Biopharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Additional Paid-In Capital	Get a 7-Day Free Trial															-	-136.94	-	-76.76	-

Zhejiang Garden Biopharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Zhejiang Garden Biopharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Zhejiang Garden Biopharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Garden Biopharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Garden Biopharmaceutical Co Ltd (SZSE:300401) » Definitions » Additional Paid-In Capital

Traded in Other Exchanges

N/A

Address

No. 166, Street 20, Economic & Technological Development Zone, Zhejiang, Hangzhou, CHN, 310018

Website

http://www.hybiotech.com

Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.

Executives

Shao Xu Jun	Director
Liu Xiao Ping	Executives
Shao Qin Xiang	Director
Shao Jun Fang	Director
Liu Jian Gang	Directors, executives
Qian Guo Ping	Executives
Zhu Jian Xing	Supervisors
Yu Quan Heng	Directors, executives, directors
Ma Huan Zheng	Directors, executives
Li Hui Ying	Supervisors
Ma Wen De	Director
Chen Yi	Executives
Gu Yi Kang	Independent director

Zhejiang Garden Biopharmaceutical Co Headlines

No Headlines